Literature DB >> 35209983

Distribution and drug resistance profiles of pathogens causing bloodstream infection after chemotherapy in children with acute lymphoblastic leukemia.

Yu-Xiao Zhan1, Jian Zhang, Cai-Fang Fan, Wen-Juan Fan, Min Xu.   

Abstract

OBJECTIVES: To study the changes in the distribution and drug resistance profiles of pathogens causing bloodstream infection after chemotherapy in children with acute lymphoblastic leukemia.
METHODS: The medical data were collected from the children with acute lymphoblastic leukemia who were admitted to the First Affiliated Hospital of Zhengzhou University between January 2015 and December 2020 and developed bloodstream infection after chemotherapy. The samples were divided into the first three years group and the next three years group according to the time of testing to investigate the differences in the distribution and drug resistance profiles of pathogens as time.
RESULTS: A total of 235 strains of pathogens were isolated, among which there were 159 Gram-negative strains (67.7%; mainly Escherichia coli and Klebsiella pneumoniae), 61 Gram-positive strains (26.0%; mainly Staphylococcus epidermidis), and 15 strains of fungi (6.4%; mainly Candida albicans). There were no significant differences between the first three years group and the next three years group in the detection rate of Gram-negative bacteria (68.8% vs 66.9%, P>0.05) or Gram-positive bacteria (29.2% vs 23.7%, P>0.05). Compared with the first three years group, the next three years group had significant increases in the detection rate of Streptococcus mitis (5.8% vs 0.0%, P<0.05) and fungi (9.4% vs 2.1%, P<0.05). There was no significant difference in the drug resistance rate of Gram-negative or Gram-positive bacteria between the two groups (P>0.05).
CONCLUSIONS: Enterobacteriaceae bacteria are the main pathogens of bloodstream infection after chemotherapy in children with acute lymphoblastic leukemia, while the detection rates of Streptococcus mitis and fungi tend to increase as time, which needs to be taken seriously in clinical practice.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Bloodstream infection; Child; Drug resistance; Pathogen

Mesh:

Substances:

Year:  2022        PMID: 35209983      PMCID: PMC8884058          DOI: 10.7499/j.issn.1008-8830.2109023

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  10 in total

1.  [Antimicrobial resistance changes of carbapenem-resistant Enterobacteriaceae strains isolated from children].

Authors:  Y Guo; F P Hu; D M Zhu; C Q Wang; A M Wang; H Zhang; C Wang; F Dong; J H Zhen; S P Zhou; Y Zhou; L Zhu; J H Meng
Journal:  Zhonghua Er Ke Za Zhi       Date:  2018-12-02

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  The associations between maternal factors during pregnancy and the risk of childhood acute lymphoblastic leukemia: A meta-analysis.

Authors:  Kangkang Yan; Xuejing Xu; Xiaodong Liu; Xikui Wang; Shucheng Hua; Chunpeng Wang; Xin Liu
Journal:  Pediatr Blood Cancer       Date:  2015-03-01       Impact factor: 3.167

4.  Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges.

Authors:  Zoi Dorothea Pana; Dimitrios Kotzadamis; Emmanuel Roilides
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

5.  [Diagnosis and therapy for childhood solid tumor and current situation in China].

Authors:  J Y Tang
Journal:  Zhonghua Er Ke Za Zhi       Date:  2017-10-02

6.  Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies.

Authors:  Sebastian Scheich; Sarah Weber; Claudia Reinheimer; Thomas A Wichelhaus; Michael Hogardt; Volkhard A J Kempf; Johanna Kessel; Hubert Serve; Björn Steffen
Journal:  Ann Hematol       Date:  2018-07-04       Impact factor: 3.673

7.  The International comparison of Systems of care and patient outcomes In minor Stroke and Tia (InSIST) study: A community-based cohort study.

Authors:  Christopher R Levi; Daniel Lasserson; Debbie Quain; Jose Valderas; Helen M Dewey; P Alan Barber; Neil Spratt; Dominique A Cadilhac; Valery Feigin; Hossein Zareie; Carlos Garcia Esperon; Andrew Davey; Nashwa Najib; Parker Magin
Journal:  Int J Stroke       Date:  2019-01-04       Impact factor: 5.266

8.  Clinical Characteristics of Bloodstream Infections in Pediatric Acute Leukemia: A Single-center Experience with 231 Patients.

Authors:  Jia-Feng Yao; Nan Li; Jin Jiang
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

9.  [Bacterial distribution and drug resistance of pathogens of blood stream infection in children with hematological malignancies after chemotherapy].

Authors:  Y Z Zheng; J Li; S H Le; H Zheng; X L Hua; Z S Chen; L Zheng; C Chen; J D Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-03-14

10.  Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.

Authors:  Maryke J Nielsen; Sarah Claxton; Barry Pizer; Steven Lane; Richard P D Cooke; Stéphane Paulus; Enitan D Carrol
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.